181 related articles for article (PubMed ID: 19802659)
21. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
22. Prevention of postoperative venous thromboembolism in Japanese patients undergoing total hip or knee arthroplasty: two randomized, double-blind, placebo-controlled studies with three dosage regimens of enoxaparin.
Fuji T; Ochi T; Niwa S; Fujita S
J Orthop Sci; 2008 Sep; 13(5):442-51. PubMed ID: 18843459
[TBL] [Abstract][Full Text] [Related]
23. The negative predictive value of D-dimer on the risk of recurrent venous thromboembolism in patients with multiple previous events: a prospective cohort study (the PROLONG PLUS study).
Ageno W; Cosmi B; Ghirarduzzi A; Santoro R; Bucherini E; Poli D; Prisco D; Alatri A; Pengo V; Galli L; Dentali F; Palareti G
Am J Hematol; 2012 Jul; 87(7):713-5. PubMed ID: 22488507
[TBL] [Abstract][Full Text] [Related]
24. Incidence and time course of asymptomatic deep vein thrombosis with fondaparinux in patients undergoing total joint arthroplasty.
Yamaguchi T; Hasegawa M; Niimi R; Sudo A
Thromb Res; 2010 Oct; 126(4):e323-6. PubMed ID: 20451962
[TBL] [Abstract][Full Text] [Related]
25. Is routine chemoprophylaxis necessary for prevention of venous thromboembolism following knee arthroplasty in a low incidence population?
Cho KY; Kim KI; Khurana S; Bae DK; Jin W
Arch Orthop Trauma Surg; 2013 Apr; 133(4):551-9. PubMed ID: 23381297
[TBL] [Abstract][Full Text] [Related]
26. New pentasaccharides for the prophylaxis of venous thromboembolism: clinical studies.
Turpie AG; Eriksson BI; Bauer KA; Lassen MR
Chest; 2003 Dec; 124(6 Suppl):371S-378S. PubMed ID: 14668420
[TBL] [Abstract][Full Text] [Related]
27. Safety of fondaparinux to prevent venous thromboembolism in Japanese patients undergoing colorectal cancer surgery: a multicenter study.
Hata T; Yasui M; Murata K; Okuyama M; Ohue M; Ikeda M; Ueshima S; Kitani K; Hasegawa J; Tamagawa H; Fujii M; Ohkawa A; Kato T; Morita S; Fukuzaki T; Mizushima T; Sekimoto M; Nezu R; Doki Y; Mori M;
Surg Today; 2014 Nov; 44(11):2116-23. PubMed ID: 24840400
[TBL] [Abstract][Full Text] [Related]
28. Single-dose TB-402 or rivaroxaban for the prevention of venous thromboembolism after total hip replacement. A randomised, controlled trial.
Verhamme P; Gunn S; Sonesson E; Peerlinck K; Vanassche T; Vandenbriele C; Ageno W; Glazer S; Prins M; Buller H; Tangelder M
Thromb Haemost; 2013 Jun; 109(6):1091-8. PubMed ID: 23615791
[TBL] [Abstract][Full Text] [Related]
29. Rate of venous thromboembolism after complex lower-limb fracture surgery without pharmacological prophylaxis.
Niikura T; Sakai Y; Lee SY; Iwakura T; Kuroda R; Kurosaka M
J Orthop Surg (Hong Kong); 2015 Apr; 23(1):37-40. PubMed ID: 25920641
[TBL] [Abstract][Full Text] [Related]
30. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped.
Palareti G; Legnani C; Cosmi B; Guazzaloca G; Pancani C; Coccheri S
Thromb Haemost; 2002 Jan; 87(1):7-12. PubMed ID: 11848459
[TBL] [Abstract][Full Text] [Related]
31. The relationships among hemostatic markers, the withdrawal of fondaparinux due to a reduction in hemoglobin and deep vein thrombosis in Japanese patients undergoing major orthopedic surgery.
Hasegawa M; Wada H; Wakabayashi H; Yoshida K; Miyamoto N; Asanuma K; Matsumoto T; Ohishi K; Shimokariya Y; Yamada N; Uchida A; Sudo A
Clin Chim Acta; 2013 Oct; 425():109-13. PubMed ID: 23876378
[TBL] [Abstract][Full Text] [Related]
32. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.
Bauer KA; Eriksson BI; Lassen MR; Turpie AG;
N Engl J Med; 2001 Nov; 345(18):1305-10. PubMed ID: 11794149
[TBL] [Abstract][Full Text] [Related]
33. Associations between venous thromboembolism onset, D-dimer, and soluble fibrin monomer complex after total knee arthroplasty.
Mitani G; Takagaki T; Hamahashi K; Serigano K; Nakamura Y; Sato M; Mochida J
J Orthop Surg Res; 2015 Nov; 10():172. PubMed ID: 26555394
[TBL] [Abstract][Full Text] [Related]
34. Postoperative prophylactic effect of fondaparinux for prevention of deep venous thrombosis after cemented total hip replacement: a comparative study.
Kawaji H; Ishii M; Tamaki Y; Hamasaki M; Ishikawa H; Sasaki K; Dairaku K; Takagi M
Mod Rheumatol; 2012 Apr; 22(2):216-22. PubMed ID: 21761228
[TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness of extended prophylaxis with fondaparinux compared with low molecular weight heparin against venous thromboembolism in patients undergoing hip fracture surgery.
Lundkvist J; Bergqvist D; Jönsson B
Eur J Health Econ; 2007 Dec; 8(4):313-23. PubMed ID: 17225129
[TBL] [Abstract][Full Text] [Related]
36. D-dimer testing cannot rule out thromboembolism after major lower extremity arthroplasties and thromboprophylaxis treatment.
Sugimoto E; Kuroda T; Fujita Y; Namba Y; Mitani S
J Anesth; 2015 Oct; 29(5):686-9. PubMed ID: 25957116
[TBL] [Abstract][Full Text] [Related]
37. A meta-analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery.
Turpie AG; Eriksson BI; Lassen MR; Bauer KA
J South Orthop Assoc; 2002; 11(4):182-8. PubMed ID: 12597061
[TBL] [Abstract][Full Text] [Related]
38. Venous thromboembolism prophylaxis: role of factor xa inhibition by fondaparinux.
Turpie AG
Surg Technol Int; 2004; 13():261-7. PubMed ID: 15744699
[TBL] [Abstract][Full Text] [Related]
39. [Perioperative changes of the coagulation markers in patients undergoing hip fracture surgery].
Okamura K; Nakagawa I; Hidaka S; Okada Y; Kubo T; Kato T
Masui; 2007 Nov; 56(11):1353-7. PubMed ID: 18027607
[TBL] [Abstract][Full Text] [Related]
40. [Prevention of venous thromboembolism and anticoagulant therapy].
Yorozu T
Masui; 2014 Mar; 63(3):278-86. PubMed ID: 24724437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
